Sally Wang Liang

Managing Partner at Xpanse Venture

Speaker

Sally Wang Liang JD MPH is Managing Partner at Xpanse Venture. She has been a biotech venture capitalist, previously as Partner at Highlight Capital (HLC), co-leading the life sciences VC group of an internationally ranked Growth Equity and Venture Capital firm with $3.8B under management, and Venture Partner at Viva Bioinnovator, a corporate VC, where she managed 11 of their portfolio companies, 8 on the Board. She is also actively involved in the biotech startup ecosystem: as an Advisory Board member of Harvard Medical School Initiative for RNA Medicine, Boulder Peptide Foundation, and as Expert-in-Residence at the Harvard iLab.

She has over 20 years of life sciences, biopharma, and healthcare industry experience. Before becoming a VC, she was SVP of Business Development at a Peptide Therapeutics company, and Entrepreneur-in-Residence (Acting VP of Investments and General Counsel) at a firm involved in newco formation from promising university technology. Her work as an investor is grounded in her experience as an entrepreneur and founder: CEO and Co-founder of an international telemedicine company and Chief Strategy Officer and EVP of IP and Regulatory of a leading digital therapeutics company. Earlier in her career, as a lawyer, she practiced pharmaceutical patent litigation and IP licensing at the premier intellectual property firm and clerked for a federal judge. She was also involved in healthcare policy making on the national level at the Food and Drug Administration Office of Policy and the US Senate Health Education Labor Pension Committee Health Office. She began her career as a management consultant at Clarion Healthcare (now Lumanity), advising many of the world’s largest pharmaceutical companies and top biotech firms on business strategy. Sally received a A.B. in Biology from Harvard College, a J.D. from Harvard Law School, and a M.P.H from Harvard T.H. Chan School of Public Health.